Onward Therapeutics Acquisition of Minority Stakes in Biomunex and EMERCell

IN BRIEF: Dechert, PMLC Avocats, advised on the matter.

Dechert advised Biomunex Pharmaceuticals with a team including Anne-Charlotte Rivi?e (Picture – Corporate M&A).

PMLC Avocats advised EMERCell with a team including Pierre Lafont (Tax M&A and Deal Advisory).

Read the full article on Global Legal Chronicle France

Author: Naoual Sadouqi

Leave a Reply